News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
834,064 Results
Type
Article (85706)
Company Profile (703)
Press Release (747655)
Section
Business (232280)
Career Advice (4114)
Deals (39660)
Drug Delivery (122)
Drug Development (90711)
Employer Resources (194)
FDA (17984)
Job Trends (17279)
News (395644)
Policy (39627)
Tag
Academia (2975)
Alliances (56564)
Alzheimer's disease (1368)
Approvals (17930)
Artificial intelligence (173)
Bankruptcy (396)
Best Places to Work (12564)
Biotechnology (485)
Breast cancer (197)
Cancer (1479)
Cardiovascular disease (124)
Career advice (3518)
CAR-T (112)
Cell therapy (322)
Clinical research (72020)
Collaboration (527)
Compensation (276)
COVID-19 (2811)
C-suite (120)
Data (1431)
Diabetes (184)
Diagnostics (6705)
Earnings (94799)
Employer resources (167)
Events (127378)
Executive appointments (417)
FDA (18709)
Funding (464)
Gene therapy (225)
GLP-1 (709)
Government (5049)
Healthcare (20746)
Infectious disease (2908)
Inflammatory bowel disease (126)
Interviews (808)
IPO (17651)
Job creations (5180)
Job search strategy (2856)
Layoffs (496)
Legal (10049)
Lung cancer (222)
Manufacturing (235)
Medical device (14440)
Medtech (14445)
Mergers & acquisitions (22161)
Metabolic disorders (518)
Neuroscience (1722)
NextGen Class of 2024 (7649)
Non-profit (5067)
Northern California (1761)
Obesity (293)
Opinion (249)
Patents (130)
People (64379)
Pharmaceutical (142)
Phase I (22202)
Phase II (31272)
Phase III (23573)
Pipeline (530)
Postmarket research (3548)
Preclinical (10010)
Radiopharmaceuticals (256)
Rare diseases (290)
Real estate (7373)
Regulatory (26127)
Research institute (2642)
Resumes & cover letters (649)
Southern California (1512)
Startups (4276)
United States (16434)
Vaccines (662)
Weight loss (227)
Date
Last 7 days (183)
Last 30 days (1676)
Last 365 days (36840)
2025 (101)
2024 (37631)
2023 (42569)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1264)
Arizona (230)
Asia (49525)
Australia (8729)
California (4070)
Canada (1495)
China (340)
Colorado (183)
Connecticut (192)
Europe (113337)
Florida (560)
Georgia (144)
Illinois (459)
Indiana (242)
Maryland (697)
Massachusetts (3239)
Michigan (188)
Minnesota (318)
New Jersey (1178)
New York (1141)
North Carolina (883)
Northern California (1761)
Ohio (154)
Pennsylvania (967)
South America (1648)
Southern California (1512)
Texas (595)
Washington State (439)
834,064 Results for "ocean bio chem inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LG Chem and Acies Bio Collaborate to Advance Sustainable Production of Chemicals
December 5, 2024
·
4 min read
Press Releases
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
November 25, 2024
·
5 min read
Genetown
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
Ocean Biomedical, Inc., announced that on April 18, 2024, it received a notice from The Nasdaq Stock Market LLC stating that because the Company has not yet filed its Annual Report on Form 10-K for the period ended December 31, 2023, the Company is not in compliance with Nasdaq Listing Rule 5250, which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.
April 24, 2024
·
5 min read
Drug Development
LG Chem company and AVEO Oncology Announce LG Chem’s First Proprietary Anti-Cancer Compound enters Phase 1 Clinical Study, Dosing Initiated in the U.S.
LG Chem and AVEO Oncology, an LG Chem company, announced that it has enrolled the first patient in the United States for a Phase 1 clinical study of LB-LR1109, LG Chem’s first proprietary anti-cancer investigational drug candidate.
June 13, 2024
·
4 min read
Business
X-Chem Strengthens Its Data-Driven Discovery Services With New CBO Appointment
Small molecule drug discovery acceleration experts and DNA-encoded library technology pioneers X-Chem, Inc. welcomes Paul Davie as Chief Business Officer.
June 20, 2024
·
2 min read
Pharm Country
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
Ocean Biomedical (NASDAQ: OCEA ) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his malaria therapeutic antibody discoveries, targeted to both prevent malaria infection and treat severe malaria.
May 16, 2024
·
7 min read
Press Releases
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms
August 27, 2024
·
8 min read
Press Releases
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses
October 2, 2024
·
7 min read
Press Releases
eMolecules Acquires Synple Chem AG
September 24, 2024
·
6 min read
Press Releases
Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)
November 12, 2024
·
7 min read
1 of 83,407
Next